Posts tagged as:

Motilal Oswal

We attended Aventis Pharma – APL’s recent annual general meeting (AGM). The management indicated that its focus will be on the domestic formulations business, with rural and OTC segments as the key growth drivers. APL is likely to incur some extra expenditure for establishing its presence in these segments. In CY09, APL launched 15 new [...]

{ 0 comments }

NTPC reported FY10 provisional net profit of Rs86b (up 6% y-o-y), v/s our estimate of Rs87.8 billion. Reported net profit includes several extra-ordinaries (Prior period tariff arrears, FERV adjustments, etc) and thus we await further details on the full year numbers to derive at adjusted profit. PLF for coal based power projects has declined from [...]

{ 1 comment }

Reliance Industries Limited (RIL) – Buy- Motilal Oswal

by free stock tips Broker tips

Lower light/heavy and sweet/sour differentials result in lower premiums for complex refiners such as Reliance India Ltd (RIL). However, given RIL’s cost advantage (approximately$2/bbl over US refiners) it would be able to maintain utilization levels of more than 90%, albeit at lower margins. We are reducing our gross refining margin (GRM) assumptions for FY10 from [...]

Read the full article →